期刊文献+

快速床旁检测脑钠素对急性心肌梗死患者危险分层及预后的评价 被引量:5

The Value of Rapid Bedside Measurements of BNP on Risk Stratification and Prognosis in Patients with AMI
下载PDF
导出
摘要 目的:通过快速床旁检测急性心肌梗死(Acute myocardial infarction,AMI)患者和不稳定心绞痛(Unstable angina,UA)患者血浆中BNP浓度,对比研究BNP对AMI患者危险分层及预后评价的价值。方法:入选2002年7月~2003年2月的AMI和UA患者,分为AMI组和UA组。即刻床旁抽血行床边BNP和心肌酶三项(CK-MB、Myo、TNI)的快速测定。同时观察入院时血压、心率、肺部罗音和住院期间及出院后一个月内不良事件。结果:入选AMI患者25例和UA20例。其中AMI组肺部有湿性罗音组12例和无罗音组13例。AMI组和UA组的BNP、肺部罗音和不良事件分别为(376.9±410.2)pg/ml和(45.2±20.6)pg/ml(P<0.001)、12例和4例、不良事件3例和0。有湿性罗音组和无罗音组的BNP浓度分别为(604.8±425.2)pg/ml和(149.1±81.5)pg/ml(P<0.05)、年龄分别为(71.1±13.5)岁和(61.7±11.2)岁(P<0.05)、不良事件分别为3例和0例,而两组间Myo、CPK-MB、TNI无差异性。结论:快速床旁检测AMI患者血浆中BNP浓度有助于对AMI患者进行危险分层和评价预后。 Objective: To assess the value of rapid bedside measurements of BNP on risk stratification and prognosis in patients with AMI and UA. Methods: To enroll patients with AMI and UA from 2002.7 - 2003.2 and were grouped AMI and UA. The rapid bedside measurements of BNP,CK - MB,Myo and TNI were performed. While the patients'blood pressure,heart rate , pulmonary rales and adverse cardiac events were recognized.Results: 25 patients with AMI and 20 patients with UA were enrolled. 12 patients with AMI have pulmonary rales and 13 patients without. BNP,pulmonary rales and adverse cardiac events were (376.9± 410.2)pg/ ml and (45.2± 20.6)pg/ml, 12 cases and 4 cases,3 cases and 0 in group AMI and group UA,respectively. BNP (604.8 ± 425.2) pg/ml and (149.1 ± 81.5)pg/ml(P < 0.05) ,ages were (71.1 ± 13.5)y and (61.7± 11.2)y in patients with pulmonary rales and without, respectively. Conclusion: The rapid bedside measurements of BNP can help to evaluate the risk stratification and prognosis in patients with AMI.
出处 《中国医药导刊》 2003年第2期114-115,共2页 Chinese Journal of Medicinal Guide
关键词 急性心肌梗死 不稳定心绞痛 脑钠素 心肌酶 危险分层 预后 myocardial infarction unstable angina natriuretic peptides prognosis
  • 相关文献

参考文献7

  • 1[1]Cowie MR. BNP: soon to become a routine measure in the care of patients with heart failure? Heart, 2000; 83:617 ~ 618
  • 2[2]Hobbs R. Can heart failure be diagnosed in primary care? Brain na triuretic peptide assays make it easier. BMJ, 2000; 321:188~ 189
  • 3胡大一.欧洲心脏病学会2002年学术会议总览[J].中国医药导刊,2002,4(6):457-462. 被引量:2
  • 4秦俭,何士大,华琦.心力衰竭临床与脑钠素[J].中国医药导刊,2002,4(5):336-337. 被引量:7
  • 5[5]Cohn JN, Tognoni G, Glazer RD, et al. Rationale and design of the valsartan heart failure trial: a large multinational trial to assess the ffects of valsartan, an angiotension- receptor blocker, on morbid ity and mortality in chronic congestive heart failure. J card Failure, 1999;5: 155~ 160
  • 6[6]Darbar D, Davidson NC, Gillpesie N, et al. Diagnosic value ofB type natriuretic peptide concentrations in patients with acute myocardial infarction. Am J Cardial, 1996; 78: 284 ~ 287
  • 7[7]Roberto L, Aldo PM, Serge M. What does the future hold for BNP in cardiology? Heart, 2001;86:601 ~ 602

二级参考文献20

  • 1Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretiou of B - type natriuretic peptide in comparison with those of A - type natriuretic peptide in normal subjects and patients with heart failure. Circulation, 1994; 90 (1): 195~203
  • 2Hystad ME. Klinge R, Spurkland A, et al. Contrasting cardiac regional responses of A - type and B - type natriuretic peptide to experimental chronic heart failure. Scand J Clin Lab Invest, 2000;60(4) :299~309
  • 3Yoshimura M, Yasue H, Okumura K, et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation, 1993;87(2) :464~469
  • 4Friedl W, Mair J, Thomas S, et al. Relationship between natriuretic peptides and hemodynamics in patients with heart failure at rest and after ergometric exercise. Clin Chim Acta, 1999;281(1 ~ 2):121~126
  • 5Maeda K, Tsutamoto T, Wada A, et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end - diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J, 1998; 135(5 Pt 1) :825~832
  • 6Luchner A, Muders F, Dietl O, et al. Differential expression of cardiac ANP and BNP in a rabbit model of progressive left ventricular dysfunction. Cardiovasc Res, 2001 Aug 15;51(3) :601~607
  • 7Bettencourt P, Ferreira A, Dias P, et al. Evaluation of brain natriuretic peptide in the diagnosis of heart failure. Cardiology, 2000; 93(1~2):19~ 25
  • 8Yamamoto K, Burnett JC Jr, Bermudes EA,et al. Clinical criteria and biochemical markers for the detection of systolic dysfunction. J Card Fail, 2000;6(3): 194 ~ 200
  • 9Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B - type natriuretic peptide in the diagnosis of congestive heart failure in an ur gent - care setting. J Am Coll Cardiol,2001 ;37(2) :379~385
  • 10Kato M, Kinugawa T, Ogino K, et al. Augmented response in plasma brain natriuretic peptide to dynamic exercise in patients with left vens tricular dysfunction and congestive heart failure. J Intern Med, 2000;248(4):309~315

共引文献7

同被引文献40

  • 1王岚峰,吴双,关秀茹,张蕾,沈景霞,薛凤华.脑钠素与急性心肌梗死预后关系的临床研究[J].中华心血管病杂志,2005,33(3):234-237. 被引量:66
  • 2王岚峰,吴双,关秀茹,沈景霞,薛凤华.脑钠素对心肌梗死急性期血管再通的早期诊断意义[J].中国介入心脏病学杂志,2005,13(5):333-334. 被引量:2
  • 3王长远,王晶,孙长怡,秦俭.脑钠素与心血管疾病[J].实用医学杂志,2006,22(9):1090-1091. 被引量:5
  • 4[1]Cowie MR.BNP:soon to becmne a routine measure in the care of patients with heart failure? Heart,2000;83:617~618
  • 5[2]Hobbs R.Can heart failure be diagnosed in primary care? Brain na triuretic peptide assays make it easier.BMJ,2000;321:188~189
  • 6[5]Cohn JN,Tognoni G,Glazer RD,et al.Rationale and design of the valsartan heart failure trial:a large multinational trial to assess the effects ofvalsartan,an angiotension-receptor blocker,on morbidity and mortality in chronic congestive heart failure.J card Failure,1999;5:155~160
  • 7Roberto L,Aldo PM, Serge M. What does the future hold for BNP in cardiology?Heart,2001;86:601~602.
  • 8Junnichi I, Wei C, Fumihiko K, et al. Prognostic value of combination of cardiac troponin T and B-type natriuretic peptide after initiation of treatment in patients with chronic heart failure. Clin Chem,2003, 49(12):2 020~2 026.
  • 9Yasue H,Yoshimura M.Localization and mechanism of secretion of B-type natriuretic peptide in comparision with those of A-type natriuretic peptide in normal subjects and patients with heart failure.Circulation,1994,90(1):195~203.
  • 10Hysrad ME.Klinge R,Spurkland A,et al.Contrasting cardiac regional responses of A-type and B-type natriuretic peptide to experimental chronic heart failure.Scand J Clin Lab Invest,2000,60(4):299~309.

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部